Inhalation of environmental stressors & chronic inflammation: Autoimmunity and neurodegeneration

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 674, Issue 1-2, 2009, Pages 62-72

  Gomez Mejiba, Sandra E ^a   Zhai, Zili ^a   Akram, Hammad ^a   Pye, Quentin N ^a   Hensley, Kenneth ^a   Kurien, Biji T ^a   Scofield, R Hal ^a,b   Ramirez, Dario C ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Chronic inflammatory disease; Environmental stressor; Inflammation; Lung; Metabolic stressor; Oxidative stress

Indexed keywords

BIOLOGICAL MARKER;

AIR POLLUTION; AUTOIMMUNE DISEASE; CHRONIC INFLAMMATION; DISEASE MARKER; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; ENVIRONMENTAL STRESS; EXPOSURE; HUMAN; IMMUNOLOGICAL TOLERANCE; LIFE EXPECTANCY; LUNG PARENCHYMA; METABOLIC STRESS; MOLECULAR MECHANICS; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; POLLUTION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW;

AIR POLLUTANTS; AUTOIMMUNITY; BRONCHITIS, CHRONIC; CHRONIC DISEASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; INHALATION EXPOSURE; MODELS, BIOLOGICAL; NERVE DEGENERATION; OXIDATIVE STRESS;

EID: 62049085854     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2008.09.016     Document Type: Review

References (120)

1. Kaiser J. Mounting evidence indicts fine-particle pollution. Science 307 (2005) 1858-1859
2. Finkel T., and Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 408 (2000) 239-247
3. Walter R., Gottlieb D.J., and O'Connor G.T. Environmental and genetic risk factors and gene-environment interactions in the pathogenesis of chronic obstructive lung disease. Environ. Health Perspect. 108 Suppl. 4 (2000) 733-742
4. Aoshiba K., and Nagai A. Chronic lung inflammation in aging mice. FEBS Lett. 581 (2007) 3512-3516
5. Jirtle R.L., and Skinner M.K. Environmental epigenomics and disease susceptibility. Nat. Rev. Genet. 8 (2007) 253-262
6. Harel-Meir M., Sherer Y., and Schoenfeld Y. Tobacco smoking and autoimmune rheumatic diseases. Nat. Clin. Practice Rheumatol. 3 (2007) 707-715
7. Nel A., and Atmosphere. Air pollution-related illness: effects of particles. Science 308 (2005) 804-806
8. Liu L., Ruddy T.D., Dalipaj M., Szyszkowicz M., You H., Poon R., Wheeler A., and Dales R. Influence of personal exposure to particulate air pollution on cardiovascular physiology and biomarkers of inflammation and oxidative stress in subjects with diabetes. J. Occup. Environ. Med. 49 (2007) 258-265
9. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., and Greenamyre J.T. Chronic pesticide exposure reproduces feature of Parkinson's disease. Nat. Neurosci. 3 (2000) 1301-1306
10. Whitton P.S. Inflammation as a causative factor in the aetiology of Parkinson's disease. Br. J. Pharmacol. 150 (2007) 963-976
11. Johnston C.J., Driscoll K.E., Finkelstein J.N., Baggs R., O'Reilly M.A., Carter J., Gelein R., and Oberdörster G. Pulmonary chemokine and mutagenic responses in rats after subchronic inhalation of amorphous and crystalline silica. Toxicol. Sci. 56 (2000) 405-413
12. Risom L., Dybdahl M., Moller P., Wallin H., Haug T., Vogel U., Klungland A., and Loft S. Repeated inhalations of diesel exhaust particles and oxidatively damaged DNA in young oxoguanine DNA glycosylase (OGG1) deficient mice. Free. Radic. Res. 41 (2007) 172-181
13. Risom L., Moller P., and Loft S. Oxidative stress-induced DNA damage by particulate air pollution. Mutat. Res. d 592 (2005) 119-137
14. Rahman I., and Adcock I.M. Oxidative stress and redox regulation of lung inflammation in COPD. Eur. Respir. J. 28 (2006) 219-242
15. Kharitonov S.A., and Barnes P.J. Exhaled biomarkers. Chest 130 (2006) 1541-1546
16. Nel A., Xia T., Madler L., and Li N. Toxic potential of materials at the nanolevel. Science 311 (2006) 622-627
17. Rahman I., Biswas S.K., and Kode A. Oxidant and antioxidant balance in the airways and airway diseases. Eur. J. Pharmacol. 533 (2006) 222-239
18. Davies K.J. Oxidative stress: the paradox of aerobic life. Biochem. Soc. Symp. 61 (1995) 1-31
19. Negre-Salvayre A., Coatrieux C., Ingueneau C., and Salvayre R. Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br. J. Pharmacol. 153 (2008) 6-20
20. McNee W. Oxidative stress and lung inflammation in airways disease. Eur. J. Pharmacol. 429 (2001) 195-207
21. Gorbunov N.V., Das D.K., Goswami S.K., Gurusamy N., and Atkins J.L. Spatial coordination of cell-adhesion molecules and redox cycling of iron in the microvascular inflammatory response to pulmonary injury. Antioxid. Redox Signal 9 (2007) 483-495
22. Barnes P.J. New molecular targets for the treatment of neutrophilic diseases. J. Allergy Clin. Immunol. 119 (2007) 1055-1062 quiz 1063-1064
23. Thacker E.L. Lung inflammatory responses. Vet. Res. 37 (2006) 469-486
24. Li X.Y., Gilmour P.S., Donaldson K., and MacNee W. Free radical activity and pro-inflammatory effects of particulate air pollution (PM10) in vivo and in vitro. Thorax 51 (1996) 1216-1222
25. Alfaro-Moreno E., Nawrot T.S., Nemmar A., and Nemery B. Particulate matter in the environment: pulmonary and cardiovascular effects. Curr. Opin. Pulm. Med. 13 (2007) 98-106
26. Chignard M., and Balloy V. Neutrophil recruitment and increased permeability during acute lung injury induced by lipopolysaccharide. Am. J. Physiol. Lung Cell Mol. Physiol. 279 (2000) L1083-L1090
27. Dröge W. Free radicals in the physiological control of cell function. Physiol. Rev. 82 (2002) 47-95
28. Donnelly L.E., and Barnes P.J. Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease. Trends Pharmacol. Sci. 27 (2006) 546-553
29. Idzko M., Hammad H., Van Nimwegen M., Kool M., Willart M.A.M., Muskens F., Hoogsteden H.C., Luttmann W., Ferrari D., Di Vigilio F., Virchow Jr. C.J., and Lambrecht B.N. Extracellular ATP triggers and mantains asthmatic airway inflammation by activating dendritic cells. Nat. Med. 13 (2007) 913-919
30. Edgington S.M. as we live and breathe: Free radicals and aging. Nat. Biotechnol. 12 (1994) 37-40
31. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J. Neurochem. 97 (2006) 1634-1658
32. Uchida K. A lipid-derived endogenous inducer of COX-2: a bridge between inflammation and oxidative stress. Mol. Cells 25 (2008) 347-351
33. Thomas E.L. Myeloperoxidase-hydrogen peroxide-chloride antimicrobial system: effect of exogenous amines on antibacterial action against Escherichia coli. Infect. Immun. 25 (1979) 110-116
34. Karin M., and Greten F.R. NF-kB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5 (2005) 749-759
35. Kutuk O., and Basaga H. Inflammation meets oxidation: NF-kB as a mediator of initial lesion development in atherosclerosis. Trends Mol. Med. 9 (2003) 549-557
36. Chung K.F., and Adcock I.M. Signaling and transcriptional regulation in inflammatory and immune cells: importance in lung biology and disease. Eur. Respir. J. 26 (2005) 762-763
37. Grune T., and Davies K.J. The proteasomal system and HNE-modified proteins. Mol. Aspects Med. 24 (2003) 195-204
38. Dalle-Donne I., Rossi R., Colombo R., Giustarini D., and Milzani A. Biomarkers of oxidative damage in human disease. Clin. Chem. 52 (2006) 601-623
39. Sato K., Kadiiska M., Ghio A., Corbett J., Fann Y.C., Holland S.M., Thurman R.G., and Mason R.P. In vivo lipid-derived free radical formation by NADPH oxidase in acute lung injury induced by lipopolysaccharide: a model for ARDS. FASEB J. 16 (2002) 1713-1720
40. Negre-Salvayre A., Vieira O., Escargueil-Blanc I., and Salvayre R. Oxidized LDL and 4-hydroxynonenal modulate tyrosine kinase receptor activity. Mol. Aspects Med. 24 (2003) 251-261
41. Niwa Y., Hiura Y., Sawamura H., and Iwai N. Inhalation exposure to carbon black induces inflammatory response in rats. Circ. J. 72 (2008) 144-149
42. Sin D.D., and Man S.F. Systemic inflammation and mortality in chronic obstructive pulmonary disease. Can. J. Physiol. Pharmacol. 85 (2007) 141-147
43. Yanbaeva D.G., Dentener M.A., Creutzberg E.C., Wesseling G., and Wouters E.F. Systemic effects of smoking. Chest 131 (2007) 1557-1566
44. Henson P.M. Dampening inflammation. Nat. Immunol. 6 (2005) 1179-1181
45. Kurien B.T., Hensley K., Bachmann M., and Scofield R.H. Oxidatively modified autoantigens in autoimmune diseases. Free Radic. Biol. Med. 41 (2006) 549-556
46. Ethen C.M., Reilly C., Feng X., Olsen T.W., and Ferrington D.A. Age-related macular degeneration and retinal protein modification by 4-hydroxy-2-nonenal. Invest. Ophthalmol. Vis. Sci. 48 (2007) 3469-3479
47. Scofield R.H., Kaufman K.M., Baber U., James J.A., Harley J.B., and Kurien B.T. Immunization of mice with human 60-kDa Ro peptides results in epitope spreading if the peptides are highly homologous between human and mouse. Arthritis Rheum. 42 (1999) 1017-1024
48. Petersen D.R., and Doorn J.A. Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic. Biol. Med. 37 (2004) 937-945
49. Federico A., Morgillo F., Tuccillo C., Ciardiello F., and Loguercio C. Chronic inflammation and oxidative stress in human carcinogenesis. Int. J. Cancer 121 (2007) 2381-2386
50. Poli G., Biasi F., and Leonarduzzi G. 4-hydroxynonenal-protein adducts: a reliable biomarker of lipid oxidation in liver diseases. Mol. Asp. Med. 29 (2008) 67-71
51. Uchida K. Future of toxicology-lipid peroxidation in the future: from biomarker to etiology. Chem. Res. Toxicol. 20 (2007) 3-5
52. Uchida K. Lipid peroxidation and redox-sensitive signaling pathways. Curr. Atheroscler. Rep. 9 (2007) 216-221
53. Tetrault G.A. Air pollution and lung function. N. Engl. J. Med. 351 (2004) 2652-2653 author reply 2652-2653
54. Fogarty A.W., Jones S., Britton J.R., Lewis S.A., and McKeever T.M. Systemic inflammation and decline in lung function in a general population: a prospective study. Thorax 62 (2007) 515-520
55. Walter R.E., Wilk J.B., Larson M.G., Vasan R.S., Keaney Jr. J.F., Lipinska I., O'Connor G.T., and Benjamin E.J. Systemic inflammation and COPD: the Framingham heart study. Chest 133 (2008) 19-25
56. Malfertheiner P., and Schütte K. Smoking-A trigger for chronic inflammation and cancer development in the pancreas. Am. J. Gastroenterol. 101 (2006) 160-162
57. Uchida K. Cellular response to bioactive lipid peroxidation products. Free Radic. Res. 33 (2000) 731-737
58. Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog. Lipid Res. 42 (2003) 318-343
59. Borm P.J., and Muller-Schulte D. Nanoparticles in drug delivery and environmental exposure: same size, same risks?. Nanomedicine 1 (2006) 235-249
60. Nurkiewicz T.R., Porter D.W., Hubbs A.F., Cumpston J.L., Chen B.T., Frazer D.G., and Castranova V. Nanoparticle inhalation augments particle-dependent systemic microvascular dysfunction. Part. Fibre. Toxicol. 5 (2008) 1
61. Kitz R., Rose M.A., Placzek K., Schulze J., Zielen S., and Schubert R. LPS inhalation challenge: a new tool to characterize the inflammatory response in humans. Med. Microbiol. Immunol. 197 (2008) 13-19
62. Saxon A., and Diaz-Sanchez D. Air pollution and allergy: you are what you breathe. Nat. Immunol. 6 (2005) 223-226
63. Diaz-Sanchez D., Tsien A., Fleming J., and Saxon A. Combined diesel exhaust particulate and ragweed allergen challenge markedly enhances human in vivo nasal ragweed-specific IgE and skews cytokine production to a T helper cell 2-type pattern. J. Immunol. 158 (1997) 2406-2413
64. Diaz-Sanchez D., Tsien A., Casillas A., Dotson A.R., and Saxon A. Enhanced nasal cytokine production in human beings after in vivo challenge with diesel exhaust particles. J. Allergy Clin. Immunol. 98 (1996) 114-123
65. Diaz-Sanchez D. Pollution and the immune response: atopic diseases-are we too dirty or too clean?. Immunology 101 (2000) 11-18
66. Bosson J., Pourazar J., Forsberg B., Adelroth E., Sandstrom T., and Blomberg A. Ozone enhances the airway inflammation initiated by diesel exhaust. Respir. Med. 101 (2007) 1140-1146
67. Murao S., Stevens F.J., Ito A., and Huberman E. Myeloperoxidase: a myeloid cell nuclear antigen with DNA-binding properties. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 1232-1236
68. Chevrier I., Stucker I., Houllier A.M., Cenee S., Beaune P., Laurent-Puig P., and Loriot M.A. Myeloperoxidase: new polymorphisms and relation with lung cancer risk. Pharmacogenetics 13 (2003) 729-739
69. Van Schooten F.J., Boots A.W., Knaapen A.M., Godschalk R.W., Maas L.M., Borm P.J., Drent M., and Jacobs J.A. Myeloperoxidase (MPO)-463G→A reduces MPO activity and DNA adduct levels in bronchoalveolar lavages of smokers. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 828-833
70. Knaapen A.M., Gungor N., Schins R.P., Borm P.J., and Van Schooten F.J. Neutrophils and respiratory tract DNA damage and mutagenesis: a review. Mutagenesis 21 (2006) 225-236
71. Ramos D.R., Garcia M.V., Canle L.M., Santaballa J.A., Furtmuller P.G., and Obinger C. Myeloperoxidase-catalyzed chlorination: the quest for the active species. J. Inorg. Biochem. 102 (2008) 1300-1311
72. Klebanoff S.J. Myeloperoxidase: friend and foe. J. Leukoc. Biol. 77 (2005) 598-625
73. Davies M.J., Hawkins C.L., Pattison D.I., and Rees M.D. Mammalian heme peroxidases: from molecular mechanisms to health implications. Antioxid. Redox Signal 7 (2008) 1199-1234
74. Foote C.S., Goyne T.E., and Lehrer R.I. Assessment of chlorination by human neutrophils. Nature 301 (1983) 715-716
75. Haegens A., Vernooy J.H., Heeringa P., Mossman B.T., and Wouters E.F. Myeloperoxidase modulates lung epithelial responses to pro-inflammatory agents. Eur. Respir. J. 31 (2008) 252-260
76. Furtmuller P.G., Obinger C., Hsuanyu Y., and Dunford H.B. Mechanism of reaction of myeloperoxidase with hydrogen peroxide and chloride ion. Eur. J. Biochem. 267 (2000) 5858-5864
77. Shen Z., Wu W., and Hazen S.L. Activated leukocytes oxidatively damage DNA, RNA, and the nucleotide pool through halide-dependent formation of hydroxyl radical. Biochemistry 39 (2000) 5474-5482
78. Masuda M., Suzuki T., Friesen M.D., Ravanat J.L., Cadet J., Pignatelli B., Nishino H., and Ohshima H. Chlorination of guanosine and other nucleosides by hypochlorous acid and myeloperoxidase of activated human neutrophils. Catalysis by nicotine and trimethylamine. J. Biol. Chem. 276 (2001) 40486-40496
79. Saxon A., and Diaz-Sanchez D. Diesel exhaust as a model xenobiotic in allergic inflammation. Immunopharmacology 48 (2000) 325-327
80. Diaz-Sanchez D., and Riedl M. Diesel effects on human health: a question of stress?. Am. J. Physiol. Lung Cell Mol. Physiol. 289 (2005) L722-723
81. Barraza-Villarreal A., Sunyer J., Hernandez-Cadena L., Escamilla-Nunez M.C., Sienra-Monge J.J., Ramirez-Aguilar M., Cortez-Lugo M., Holguin F., Diaz-Sanchez D., Olin A.C., and Romieu I. Air pollution, airway inflammation, and lung function in a cohort study of Mexico City schoolchildren. Environ. Health Perspect. 116 (2008) 832-838
82. Hollingsworth J.W., Kleeberger S.R., and Foster W.M. Ozone and pulmonary innate immunity. Proc. Am. Thorac. Soc. 4 (2007) 240-246
83. Hollingsworth II J.W., Cook D.N., Brass D.M., Walker J.K., Morgan D.L., Foster W.M., and Schwartz D.A. The role of Toll-like receptor 4 in environmental airway injury in mice. Am. J. Respir. Crit. Care Med. 170 (2004) 126-132
84. Hollingsworth J.W., Chen B.J., Brass D.M., Berman K., Gunn M.D., Cook D.N., and Schwartz D.A. The critical role of hematopoietic cells in lipopolysaccharide-induced airway inflammation. Am. J. Respir. Crit. Care Med. 171 (2005) 806-813
85. Hamahata A., Enkhbaatar P., Kraft E.R., Lange M., Leonard S.W., Traber M.G., Cox R.A., Schmalstieg F.C., Hawkins H.K., Whorton E.B., Horvath E.M., Szabo C., Traber L.D., Herndon D.N., and Traber D.L. Gamma-tocopherol nebulization by a lipid aerosolization device improves pulmonary function in sheep with burn and smoke inhalation injury. Free Radic. Biol. Med. 45 (2008) 425-433
86. Kurien B.T., and Scofield R.H. Free radical mediated peroxidative damage in systemic lupus erythematosus. Life Sci. 73 (2003) 1655-1666
87. Kurien B.T., and Scofield R.H. Lipid peroxidation in systemic lupus erythematosus. Indian J. Exp. Biol. 44 (2006) 349-356
88. Seven A., Guzel S., Aslan M., and Hamuryudan V. Lipid, protein, DNA oxidation and antioxidant status in rheumatoid arthritis. Clin. Biochem. 41 (2008) 538-543
89. Ahsan H., Ali A., and Ali R. Oxygen free radicals and systemic autoimmunity. Clin. Exp. Immunol. 131 (2003) 398-404
90. Eggleton P., Haigh R., and Winyard P.G. Consequence of neo-antigenicity of the 'altered self'. Rheumatology (Oxford) 47 (2008) 567-571
91. Kannan S. Free radical theory of autoimmunity. Theor. Biol. Med. Model. 3 (2006) 1-16
92. Doyle H.A., and Mamula M.J. Posttranslational modifications of self-antigens. Ann. N. Y. Acad. Sci. 1050 (2005) 1-9
93. Scofield R.H., Kurien B.T., Ganick S., McClain M.T., Pye Q., James J.A., Schneider R.I., Broyles R.H., Bachmann M., and Hensley K. Modification of lupus-associated 60-kDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading. Free Radic. Biol. Med. 38 (2005) 719-728
94. Arbuckle M.R., McClain M.T., Rubertone M.V., Scofield R.H., Dennis G.J., James J.A., and Harley J.B. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349 (2003) 1526-1533
95. Scofield R.H. Autoantibodies as predictors of disease. Lancet 363 (2004) 1544-1546
96. Boyd G.W. An evolution-based hypothesis on the origin and mechanisms of autoimmune disease. Immunol. Cell Biol. 75 (1997) 503-507
97. Rose N.R. Mechanisms of autoimmunity. Semin. Liver Dis. 22 (2002) 387-394
98. Lehmann P.V., Forsthuber T., Miller A., and Sercarz E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358 (1992) 155-157
99. James J.A., Gross T., Scofield R.H., and Harley J.B. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B′-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J. Exp. Med. 181 (1995) 453-461
100. Scofield R.H., Henry W.E., Kurien B.T., James J.A., and Harley J.B. Immunization with short peptides from the sequence of the systemic lupus erythematosus-associated 60-kDa Ro autoantigen results in anti-Ro ribonucleoprotein autoimmunity. J. Immunol. 156 (1996) 4059-4066
101. Vaarala O. Antibodies to oxidised LDL. Lupus 9 (2000) 202-205
102. Matsuura E., and Lopez L.R. Are oxidized LDL/beta2-glycoprotein I complexes pathogenic antigens in autoimmune-mediated atherosclerosis?. Clin. Dev. Immunol. 11 (2004) 103-111
103. Bashir S., Harris G., Denman M.A., Blake D.R., and Winyard P.G. Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann. Rheum. Dis. 52 (1993) 659-666
104. Farris A.D., Gross J.K., Hanas J.S., and Harley J.B. Genes for murine Y1 and Y3 Ro RNAs have class 3 RNA polymerase III promoter structures and are unlinked on mouse chromosome 6. Gene 174 (1996) 35-42
105. O'Brien C.A., and Wolin S.L. A possible role for the 60-kDa Ro autoantigen in a discard pathway for defective 5S rRNA precursors. Genes Dev. 8 (1994) 2891-2903
106. Yamagata H., Harley J.B., and Reichlin M. Molecular properties of the Ro/SSA antigen and enzyme-linked immunosorbent assay for quantitation of antibody. J. Clin. Invest. 74 (1984) 625-633
107. Serban M.G., and Tanaseanu S. Lipid peroxidation in autoimmune systemic vasculitides. Effect of corticoid treatment on lipid peroxidation. Antioxidant protection with vitamin E, Rom. J. Intern. Med. 32 (1994) 137-142
108. Grune T., Michel P., Sitte N., Eggert W., Albrecht-Nebe H., Esterbauer H., and Siems W.G. Increased levels of 4-hydroxynonenal modified proteins in plasma of children with autoimmune diseases. Free Radic. Biol. Med. 23 (1997) 357-360
109. Michel P., Eggert W., Albrecht-nebe H., and Grune T. Increased lipid peroxidation in children with autoimmune diseases. Acta Paediatr. 86 (1997) 609-612
110. Flippo T.S., and Holder Jr. W.D. Neurological degeneration associated with nitrous oxide anesthesia in patients with vitamin B12 deficiency. Arch. Surg. 128 (1993) 1395-11395
111. Culley D.J., Roghavan S.V., Waly M., Baxter M.G., Yukhananov R., Deth R.C., and Crosby G. Nitrous oxide decreases cortical methionine synthase transiently but produces lasting memory impairment in aged rats. Anesth. Analg. 105 (2007) 83-88
112. Selzer R.R., Rosenblatt D.S., Laxova R., and Hogan K. Adverse effect of nitrous oxide in child with 5,10-methylenetetrahydrofolate reductase deficiency. N. Engl. J. Med. 349 (2003) 45-50
113. Chanarin I. The effect of nitrous oxide on cobalamins, folates, and on related events. Crit. Rev. Toxicol. 10 (1982) 179-213
114. Bochkov V.N. Inflammatory profile of oxidized phospholipids. Thromb. Haemost. 97 (2007) 348-354
115. Maier K.L., Alessandrini F., Beck-Speier I., Hofer T.P., Diabaté S., Bitterle E., Stöger T., Jakob T., Behrendt H., Horsch M., Beckers J.F., Ziesenis A., Hültner L., Frankenberger M., Kraus-Etschmann S., and Schulz H. Health effects of ambient particulate matter: biological mechanisms and inflammatory responses to in vitro and in vivo particle exposure. Inhal. Toxicol. 20 (2008) 319-337
116. Hensley K., Howard B.J., Carney J.M., and Butterfield A.D. Membrane protein alterations in rodent erythrocytes and synaptosomes due to aging and hyperoxia. Biochim. Biophys. Acta 1270 (1995) 203-206
117. Howard B.J., Yatin S., Hensley K., Allen K.L., Kelly J.P., Carney J., and Butterfield A.D. Prevention of hyperoxia-induced alterations in synaptosomal membrane-associated proteins by N-tert-butyl-alpha-phenylnitrone and 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (tempol). J. Neurochem. 67 (1996) 2045-2050
118. Rojo A.I., Cavada C., de Sagarra M.R., and Cuadrado A. Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in rats or mice. Exp. Neurol. 208 (2007) 120-126
119. Gash D.M., Rutland K., Hudson N.L., Sullivan P.G., Bing G., Cass W.A., Pandya J.D., Liu M., Choi D.Y., Hunter R.L., Gerhardt G.A., Smith C.D., Slevin J.T., and Prince T.S. Trichloroethylene: parkinsonism and complex 1 mitochondrial neurotoxicity. Ann. Neurol. 63 (2008) 184-192
120. Barr D.B. Human exposure science: a field of growing importance. J. Exp. Sci. Environ. Epidemiol. 16 (2006) 473